Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma (NEXTAR)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: January 3, 2012
Last updated: January 19, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)